Andrea F. Wainer
Executive Vice President, Abbott Laboratories.
Companies
- NeoGenBoard member Jun 4, 2025 to now1
- Analog DevicesBoard member Jan 17, 2025 to now2
- Abbott LaboratoriesExecutive Vice President Jun 5, 2019 to Mar 4, 20253
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT74,381 shares4$7.8M at $104.71Mar 3, 2025
Analog Devices ADI2,375 shares5$940.0K at $395.81Mar 12, 2026
NeoGen NEOG19,769 shares6$230.6K at $11.66Oct 23, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 11, 2026Granted 747 shares of Analog Devices5
- Oct 23, 2025Granted 19,769 shares at $6.07 of NeoGen6
- Jun 2, 2025Granted 6,090 shares at $5.69 of NeoGen7
- Mar 12, 2025Granted 1,160 shares of Analog Devices8
- Mar 3, 2025Sold 949 shares at $138.17 of Abbott Laboratories4
- Feb 28, 2025Shares withheld for tax 7,313 shares at $135.87 of Abbott Laboratories4
- Feb 25, 2025Granted 12,278 shares of Abbott Laboratories9
- Feb 29, 2024Shares withheld for tax 8,339 shares at $120.05 of Abbott Laboratories10
- Feb 23, 2024Sold 12,500 shares at $120.00 of Abbott Laboratories11
- Feb 23, 2024Exercised options 12,500 shares at $59.94 of Abbott Laboratories11
- Feb 21, 2024Granted 13,677 shares of Abbott Laboratories12
- Jan 29, 2024Sold 17,500 shares at $112.50 of Abbott Laboratories13
- Jan 29, 2024Exercised options 17,500 shares at $59.94 of Abbott Laboratories13
- Jan 29, 2024Sold 25,000 shares at $112.50 of Abbott Laboratories13
- Jan 29, 2024Exercised options 25,000 shares at $44.40 of Abbott Laboratories13
- Dec 14, 2023Sold 15,000 shares at $108.00 of Abbott Laboratories14
- Dec 14, 2023Exercised options 15,000 shares at $44.40 of Abbott Laboratories14
- Aug 8, 2023Sold 16 shares at $107.42 of Abbott Laboratories15
- Aug 8, 2023Sold 272 shares at $105.43 of Abbott Laboratories15
- Aug 8, 2023Sold 5,112 shares at $105.00 of Abbott Laboratories15
- Aug 8, 2023Sold 15 shares at $107.42 of Abbott Laboratories15
- Aug 8, 2023Sold 244 shares at $105.43 of Abbott Laboratories15
- Aug 8, 2023Sold 4,741 shares at $105.00 of Abbott Laboratories15
- Aug 8, 2023Exercised options 5,000 shares at $38.40 of Abbott Laboratories15
- May 2, 2023Sold 8,226 shares at $110.56 of Abbott Laboratories16
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Mar 3, 2025 | ABT | Sale | $131.1K | −25.2% | +57.4% | +35.5% |
| Feb 23, 2024 | ABT | Sale | $1.5M | −12.2% | +64.2% | +4.6% |
| Jan 29, 2024 | ABT | Sale | $4.8M | −7.5% | +64.6% | +10.8% |
| Dec 14, 2023 | ABT | Sale | $1.6M | −3.4% | +66.9% | +23.6% |
| Aug 8, 2023 | ABT | Sale | $1.1M | −0.7% | +72.6% | +11.4% |
| May 2, 2023 | ABT | Sale | $909.5K | −5.9% | +93.8% | +26.5% |
| Mar 1, 2023 | ABT | Sale | $68.4K | +4.0% | +91.5% | +11.0% |
| Mar 1, 2022 | ABT | Sale | $53.9K | −11.2% | +90.7% | +6.5% |
| Dec 27, 2021 | ABT | Sale | $427.5K | −25.9% | +87.6% | +3.2% |
| Dec 23, 2021 | ABT | Sale | $1.8M | −24.6% | +88.6% | +3.6% |
| Dec 17, 2021 | ABT | Sale | $1.0M | −23.5% | +91.3% | +4.9% |
| Dec 13, 2021 | ABT | Sale | $2.0M | −22.9% | +88.3% | +4.1% |
| Dec 6, 2021 | ABT | Sale | $596.2K | −20.8% | +89.0% | +7.4% |
| Nov 15, 2021 | ABT | Sale | $1.6M | −19.0% | +84.1% | +5.6% |
| Sep 2, 2021 | ABT | Sale | $1.2M | −18.4% | +88.7% | +6.8% |
| Aug 17, 2021 | ABT | Sale | $1.8M | −16.5% | +90.4% | +8.1% |
| Mar 3, 2021 | ABT | Sale | $755.1K | −12.0% | +114.3% | +12.7% |
| Mar 1, 2021 | ABT | Sale | $70.8K | −14.2% | +112.3% | +13.7% |
| Sep 30, 2020 | ABT | Sale | $3.2M | −3.6% | +134.1% | +19.6% |
| Sep 23, 2020 | ABT | Sale | $374.0K | +2.1% | +137.1% | +15.4% |
| Mar 2, 2020 | ABT | Sale | $111.3K | +28.5% | +121.2% | −25.1% |
| Feb 7, 2020 | ABT | Sale | $99.2K | +19.4% | +113.0% | −24.1% |
| Jun 21, 2019 | ABT | Sale | $101.1K | +23.4% | +139.1% | −0.6% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNeoGen, Board member
- 2SEC EDGARAnalog Devices, Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 4, 2025
- 8SEC EDGARForm 4 filed Mar 14, 2025
- 9SEC EDGARForm 4 filed Feb 27, 2025
- 10SEC EDGARForm 4 filed Mar 4, 2024
- 11SEC EDGARForm 4 filed Feb 27, 2024
- 12SEC EDGARForm 4 filed Feb 23, 2024
- 13SEC EDGARForm 4 filed Jan 31, 2024
- 14SEC EDGARForm 4 filed Dec 18, 2023
- 15SEC EDGARForm 4 filed Aug 10, 2023
- 16SEC EDGARForm 4 filed May 3, 2023